Skip to main content
Paul Noble, MD, Pulmonology, West Hollywood, CA, Cedars-Sinai Medical Center

PaulWesleyNobleMD

Pulmonology West Hollywood, CA

Interstitial Lung Diseases

Chairman, Department of Medicine, Cedars-Sinai Medical Center

Dr. Noble is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Noble's full profile

Already have an account?

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1991
  • University of California (San Francisco)
    University of California (San Francisco)Chief Residency, Internal Medicine, 1987 - 1988
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1984 - 1987
  • New York University School of Medicine
    New York University School of MedicineClass of 1984

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2012 - 2024
  • NC State Medical License
    NC State Medical License 2006 - 2014
  • CT State Medical License
    CT State Medical License 1998 - 2007
  • MD State Medical License
    MD State Medical License 1992 - 1999
  • CO State Medical License
    CO State Medical License 1989 - 1993
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Press Mentions

  • Pulmonary Fibrosis Foundation Adds Cedars-Sinai to Care Center Network
    Pulmonary Fibrosis Foundation Adds Cedars-Sinai to Care Center NetworkDecember 23rd, 2022
  • Cedars-Sinai Named to Pulmonary Fibrosis Foundation Care Center Network
    Cedars-Sinai Named to Pulmonary Fibrosis Foundation Care Center NetworkDecember 16th, 2022
  • Lassen Therapeutics Announces the Appointment of a Highly Experienced Biotech Executive to Its Board of Directors and the Expansion of Its Scientific and Clinical Advisory Board with Leading Experts in Pulmonary Fibrosis and Clinical Development
    Lassen Therapeutics Announces the Appointment of a Highly Experienced Biotech Executive to Its Board of Directors and the Expansion of Its Scientific and Clinical Advisory Board with Leading Experts in Pulmonary Fibrosis and Clinical DevelopmentOctober 7th, 2021
  • Join now to see all

Grant Support

  • Innate Immune Mechanisms In Non-Infectious Lung InflammationNational Institute Of Allergy And Infectious Diseases2008–2012
  • Matrix Regulation Of Pulmonary FibrosisNational Heart, Lung, And Blood Institute2011
  • Regulation Of Pulmonary Fibrosis By CXCR3National Heart, Lung, And Blood Institute2006–2011
  • Interdisciplinary Training Program In Lung DiseaseNational Heart, Lung, And Blood Institute2006–2011
  • Mechanisms Of Macrophage Activation In Lung InflammationNational Heart, Lung, And Blood Institute2006–2010
  • Matrix Regulation Of Fibroproliferative Lung DiseaseNational Heart, Lung, And Blood Institute2006–2010
  • Immune Mechanisms In Non-Infectious Lung InflammationNational Institute Of Allergy And Infectious Diseases2006
  • Survivin Regulation Of Pulmonary FibrosisNational Heart, Lung, And Blood Institute2006
  • Regulation Of Pulmonary Fibrosis By CXCR3National Heart, Lung, And Blood Institute2005–2006
  • Survivin Regulation Of Pulmonary FibrosisNational Heart, Lung, And Blood Institute2003–2005
  • Immune Mechanisms In Non-Infectious Lung InflammationNational Institute Of Allergy And Infectious Diseases2002–2005
  • Mechanisms Of Macrophage Activation In Lung InflammationNational Heart, Lung, And Blood Institute1997–2005
  • Regulation Of Macrophage Phenotypes In Lung RepairNational Heart, Lung, And Blood Institute1992–1996

Hospital Affiliations